New Daily Cholesterol Pill Cuts Bad Cholesterol 60%

Millions of Americans with stubborn high cholesterol just got a game-changing new option that could help them avoid heart attacks and strokes.

The FDA approved Lipfendra this week, the first pill that blocks a protein called PCSK9 to dramatically lower bad cholesterol. Previous treatments targeting this same protein required uncomfortable injections, which many patients avoided.

In clinical trials, the new pill reduced bad cholesterol by 56% to 60% when combined with standard statin medications. That's roughly double the impact of statins alone, according to Fox News senior medical analyst Dr. Marc Siegel.

The drug works by targeting PCSK9, a protein left over from our hunter-gatherer days that prevents the liver from removing bad cholesterol from the blood. Back when food was scarce, this helped our ancestors survive. Today, it mainly contributes to the plaques that cause heart disease.

Merck, the New Jersey manufacturer, designed the pill for adults whose cholesterol stays high despite diet changes and other treatments. This includes people with inherited forms of high cholesterol and those who can't tolerate statins.

The good news extends beyond effectiveness. Patients in the trials tolerated the pill well, with only minor side effects like diarrhea and dizziness. Serious side effects occurred at the same rate as in patients taking a placebo.

Why This Inspires

This approval represents years of scientific effort to make lifesaving treatment more accessible. Injectable PCSK9 inhibitors like Repatha and Praluent have been available for years and work beautifully, but many patients never started them because of the injection requirement.

"The oral form, Lipfendra, is also well-tolerated and just as effective," Siegel said. Now patients can simply add a pill to their daily routine instead of learning to give themselves shots.

The timing matters too. Heart disease remains the leading cause of death in America, and high cholesterol affects nearly 94 million adults. Every barrier removed from effective treatment means more lives saved.

Researchers are now studying whether the pill also reduces heart attacks, strokes and cardiovascular deaths, with results expected in 2029. But cardiologists already know that lower bad cholesterol means lower risk, especially for people already facing heart disease.

As Dr. Steve Nissen, longtime head of preventive cardiology at Cleveland Clinic, puts it: the lower the better when it comes to bad cholesterol.